Abstract:The purpose of the present study was to prepare a clonidine hydrochloride (CH) sustained-release suspension.The processes involved in the drug formulation included drug loading, impregnating, and suspension preparation. Clonidine hydrochloride drug–resin complexes (CH-DRC) were prepared using the bath method and the CH-DRC impregnated before the microencapsulation process. Based on the bottom spray fluidized bed coating method, the CH microencapsulated drug–resin complexes (CH-MC) were also prepared using Surelease® (the suspension of ethyl cellulose aqueous dispersion) as the coating material. The effects of coating (process/formulation) on the in vitro release of coating microcapsule were evaluated via single factor investigation and orthogonal design optimization. The CH-MC with optimized formulation was further dispersed in a suitable medium to obtain a sustained-release suspension. Rats were given commercial CH ordinary tablets and the CH sustained-release suspension via intragastric administration. The plasma concentration–time curve and related pharmacokinetic parameters were investigated using the non-compartment model.The Tmax of the CH sustained-release suspension was delayed from 2 h to 5 h compared with the CH ordinary tablets. Similarly, the Cmax was reduced from 32.138 µg·mL−1 to 18.150 µg·mL−1 with the concentration–time curve being more gentle compared with the commercially CH ordinary tablets. After oral administration, the relative bioavailability of CH sustained-release suspension (AUC0–24 of 137.703 µg·h·mL−1) to its CH ordinary tablets (AUC0–24 of 123.337 µg·h·mL−1) was 111.65%.The findings showed that the CH sustained-release suspension for oral administration was successfully formulated.

Preparation and in Vitro Evaluation of the Bioadhesive Cephalexin Sustained-release Tablets

Study on pramipexole dihydrochloride sustained-release tablets

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation.

Preparation and Evaluation in Vitro for Captopril/Bioadhesive Sustained-Release Capsules

Preparation and in vitro Release of Doxazosin Mesylate Controlled-Release Tablets

Preparation and in vitro release of Naringin Buccal Adhesive Tablets

In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil

In Vitro Release Characteristic of Famotidine Bioadhesive Sustained-Release Tablets

To evaluate In Vitro and In Vivo Performances of Mucoadhesive Microspheres of Aceclofenac

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation

Optimization of penicillin acylase catalyzed synthesis of cephalexin by glycols and pH regulation

In Vitro and in Vivo Evaluation of Levofloxacin Sustained-Release Capsules.

Studies on Preparation and in vitro Drug Release of Sodium Ferulate Double-layer Tablets

Natural gum as mucoadhesive controlled release carriers: evaluation of cefpodoxime proxetil by D-optimal design technique

Study on Diclofenac Sodium Enteric-coated Sustained-release Tablets Preparation and in Vitro Release

Effect of Chemical Penetration Enhancer-Adhesive Interaction on Drug Release from Transdermal Patch: Mechanism Study Based on FT-IR Spectroscopy, 13C NMR Spectroscopy, and Molecular Simulation

Studies on preparation and evaluation of fentanyl bilayer sustained-release films

Development and characterization of lyophilized cefpodoxime proxetil-Pluronic® F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity

Optimization of Preparation Process and Pharmacokinetics of APAP Double-Release Pellet Capsules